Integral Derivatives’s Thermo Fisher Scientific TMO Stock Holding History

Integral Derivatives’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-13,900	Closed	-$2.64M	–	992
2017 Q4	$2.64M	Buy	13,900 +2,300	+20%	+$441K	0.05%	230
2017 Q3	$2.19M	Buy	11,600 +2,500	+27%	+$453K	0.04%	288
2017 Q2	$1.59M	Sell	9,100 -600	-6%	-$101K	0.03%	362
2017 Q1	$1.49M	Buy	+9,700	New	+$1.48M	0.03%	399
2016 Q1	–	Sell	-9,500	Closed	-$1.35M	–	1095
2015 Q4	$1.35M	Hold	9,500	–	–	0.03%	373
2015 Q3	$1.16M	Hold	9,500	–	–	0.03%	459
2015 Q2	$1.23M	Hold	9,500	–	–	0.03%	454
2015 Q1	$1.28M	Hold	9,500	–	–	0.03%	439
2014 Q4	$1.19M	Buy	9,500 +5,500	+138%	+$669K	0.02%	609
2014 Q3	$487K	Buy	+4,000	New	+$486K	0.01%	985
2014 Q2	–	Sell	-10,000	Closed	-$1.2M	–	1507
2014 Q1	$1.2M	Sell	10,000 -21,900	-69%	-$2.6M	0.02%	595
2013 Q4	$3.55M	Buy	+31,900	New	+$3.17M	0.05%	318

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Integral Derivatives's TMO Position: Q2 2015 in Review

Integral Derivatives sold out of Thermo Fisher Scientific (TMO) in Q2 2015, closing a stake of 3,836 shares — an estimated $500K sold.

Integral Derivatives first reported a position in TMO in Q1 2014 and held it in 5 quarters. The position peaked at $1.74M in Q1 2014. 974 funds tracked by Wall St. Rank hold TMO as of Q2 2015.

Integral Derivatives reported no remaining Thermo Fisher Scientific position as of Q2 2015 after selling out during the quarter.
Integral Derivatives sold 3,836 Thermo Fisher Scientific shares in Q2 2015, an estimated $500K.
Integral Derivatives first reported a position in Thermo Fisher Scientific in Q1 2014 and held it in 5 quarters.
Integral Derivatives's Thermo Fisher Scientific position peaked at $1.74M in Q1 2014.
974 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2015.

Based on Integral Derivatives's 13F filing for Q2 2015, filed 15 Jul 2015.